SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016675
Filing Date
2022-08-11
Accepted
2022-08-11 09:00:53
Documents
79
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fstx-20220630.htm   iXBRL 10-Q 2490175
2 EX-31.1 fstx-ex31_1.htm EX-31.1 21362
3 EX-31.2 fstx-ex31_2.htm EX-31.2 21076
4 EX-32.1 fstx-ex32_1.htm EX-32.1 11940
5 EX-32.2 fstx-ex32_2.htm EX-32.2 11956
  Complete submission text file 0000950170-22-016675.txt   9540908

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fstx-20220630_pre.xml EX-101.PRE 454268
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fstx-20220630.xsd EX-101.SCH 72059
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fstx-20220630_lab.xml EX-101.LAB 591269
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fstx-20220630_def.xml EX-101.DEF 310138
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fstx-20220630_cal.xml EX-101.CAL 54724
73 EXTRACTED XBRL INSTANCE DOCUMENT fstx-20220630_htm.xml XML 1651267
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 221153913
SIC: 2834 Pharmaceutical Preparations